Diligence memo · auto-generated · as of July 2, 2026
Ruskid Llc
Ruskid Llc looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Ruskid Llc operates in Biotechnology, based in RANCHO SANTA FE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ruskid Llc has raised $1.4M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.4M on 2026-01-16.
Most recent recorded round closed around 2026-01-16.
Valuation (modeled)modeled
Provath models Ruskid Llc at approximately $2.8M (range $986K–$5.0M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Seed Biotechnology companies in 2025–2027 (99 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 5 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 22% of Biotechnology peers (4293 compared).
Modeled value ranks above 7% of those peers.
Closest niche peers: Carna Inc., NRX Pharmaceuticals, Inc., Vicora, Inc., MH3D, Inc., Oral Genome Corp..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.